Shares of Sequenom rose 23 percent for the five-day trading period ended Tuesday to lead all gainers in the BCW Index. The firm’s shares jumped 16 percent on Tuesday alone after the firm announced that it had licensed a next-generation sequencing technology from Harvard University (see Briefs).
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.